Meridian Wealth Management, LLC
Position in DMAC — DiaMedica Therapeutics Inc.
CIK 1697300
LEXINGTON, KY
Position in DMAC
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$306,944
-$22,355 QoQ
Shares Held
43,600
-10.4% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 87 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $7,258,442 across 7 Biotechnology names. DMAC ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
22,028 | $5,391,793 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
132,256 | $751,214 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
742 | $368,573 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
This page
|
43,600 | $306,944 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
801 | $253,188 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
|
94,400 | $160,480 | |
| 7 | BYSI |
BeyondSpring Inc.
|
15,000 | $26,250 |
All Filings in DMAC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,944 | 43,600 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $329,299 | 48,641 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $403,102 | 50,641 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $354,945 | 51,666 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $106,532 | 27,316 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $109,212 | 28,816 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $147,782 | 27,216 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||